<DOC>
	<DOCNO>NCT01393197</DOCNO>
	<brief_summary>The purpose study evaluate effect Transcatheter Arterial Chemoembolization ( TACE ) KMG microsphere treat HCC . And determine one good , KMG microsphere lipiodol ?</brief_summary>
	<brief_title>Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas ( TACE-KMG )</brief_title>
	<detailed_description>The important part effect TACE embolization .But clinical trial one good , KMG microsphere lipiodol ? effect chemo play TACE treat HCC ? Which one good , routine dose low dose ? Experts USA Japan research standpoints.We think important push clinical trail answer problem .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Hepatocellular Carinomas diagnosis pathology cytology consistent China 2001 guideline Clinical Diagnosis Hepatocellular Carinomas clinical stage（The Barcelona Liver Clinic stag system , BCLC B C ) ，or receive surgical intervention liver function : ChildPugh A、B PST 0—1（Eastern Cooperative Oncology Group Performance Score , ECOG） Lifespan≥6 month First time receive treatment Can accept follow informed consent gotten number lesion ≤ 5 pregnant lactation woman emotional disturbance serious heart , lung disfunction serious diabetes mellitus serious reactiveness infection ; （exp : type B C hepatitis） liver function : ChildPugh Score C thrombocyte＜6×109/L diffuse HCC widespread metastasis serious atherosclerosis acquire immunodeficiency syndrome ; AIDS thrombosis thrombosis event 6 month renal inadequacy need hemodialysis peritoneal dialysis tumor except basal cell carcinoma carcinoma situ cervix serious alimentary tract hemorrhage 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>HCC</keyword>
	<keyword>TACE</keyword>
</DOC>